Business Description
Daiken Biomedical Co Ltd
ISIN : TW0007780009
Compare
Compare
Traded in other countries / regions
7780.Taiwan IPO Date
2024-10-28Description
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.52 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.86 | |||||
| Interest Coverage | 44.9 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.35 | |||||
| 9-Day RSI | 54.03 | |||||
| 14-Day RSI | 53.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.18 | |||||
| Quick Ratio | 3.41 | |||||
| Cash Ratio | 3.13 | |||||
| Days Inventory | 428.55 | |||||
| Days Sales Outstanding | 31.93 | |||||
| Days Payable | 96.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.45 | |||||
| Operating Margin % | 18.94 | |||||
| Net Margin % | 16.64 | |||||
| FCF Margin % | 6.39 | |||||
| ROE % | 12.95 | |||||
| ROA % | 8.44 | |||||
| ROIC % | 32.66 | |||||
| ROC (Joel Greenblatt) % | 72.53 | |||||
| ROCE % | 15.61 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 87.83 | |||||
| PE Ratio without NRI | 87.83 | |||||
| PS Ratio | 14.61 | |||||
| PB Ratio | 8.21 | |||||
| Price-to-Tangible-Book | 8.23 | |||||
| Price-to-Free-Cash-Flow | 228.74 | |||||
| Price-to-Operating-Cash-Flow | 221.05 | |||||
| EV-to-EBIT | 64.44 | |||||
| EV-to-EBITDA | 63.71 | |||||
| EV-to-Revenue | 13.32 | |||||
| EV-to-FCF | 208.55 | |||||
| Price-to-Graham-Number | 4.19 | |||||
| Price-to-Net-Current-Asset-Value | 8.34 | |||||
| Price-to-Net-Cash | 12.54 | |||||
| Earnings Yield (Greenblatt) % | 1.55 | |||||
| FCF Yield % | 0.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daiken Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 725.099 | ||
| EPS (TTM) (NT$) | 2.021 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 53.51 | ||
| 14-Day ATR (NT$) | 5.268198 | ||
| 20-Day SMA (NT$) | 175.025 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 81 - 192 | ||
| Shares Outstanding (Mil) | 60 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daiken Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daiken Biomedical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daiken Biomedical Co Ltd Frequently Asked Questions
What is Daiken Biomedical Co Ltd(ROCO:7780)'s stock price today?
The current price of ROCO:7780 is NT$177.50. The 52 week high of ROCO:7780 is NT$192.00 and 52 week low is NT$81.00.
When is next earnings date of Daiken Biomedical Co Ltd(ROCO:7780)?
The next earnings date of Daiken Biomedical Co Ltd(ROCO:7780) is .
Does Daiken Biomedical Co Ltd(ROCO:7780) pay dividends? If so, how much?
Daiken Biomedical Co Ltd(ROCO:7780) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers